Article Information
History
- January 10, 2022.
Article Versions
- You are currently viewing Version 1 of this article (January 10, 2022 - 01:42).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Yi Ju1,2,3,*,
- Wen Shi Lee1,4,
- Hannah G Kelly1,
- Emily H Pilkington1,5,
- Kathleen M Wragg1,
- Kanta Subbarao1,
- Thi H.O. Nguyen1,
- Louise C. Rowntree1,
- Lilith F Allen1,
- Katherine Bond6,
- Deborah A Williamson1,6,
- Nghia P Truong1,5,
- Magdalena Plebanski2,
- Katherine Kedzierska1,
- Siddhartha Mahanty7,
- Frank Caruso3,
- Adam K Wheatley1,
- Jennifer A Juno1 and
- Stephen J Kent1,8,*
- 1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia
- 2School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia
- 3Department of Chemical Engineering, The University of Melbourne, Melbourne, VIC, Australia
- 4The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
- 5Department of Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia
- 6Department of Microbiology, Royal Melbourne Hospital, Melbourne, VIC, Australia
- 7Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia
- 8Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia
- ↵*Corresponding authors. Email skent{at}unimelb.edu.au; y.ju{at}unimelb.edu.au
Posted January 10, 2022.
Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine
